
GC75611
DGKα-IN-2
Also known as 1-methyl-2-oxo-4-[4-[4-(trifluoromethoxy)phenoxy]piperidin-1-yl]quinoline-3-carboxamide
DGKα-IN-2 (example 48) is a DGKα inhibitor with the IC50 of 0·9 nM, extracted from patent WO2021105115
ChemicalCAS2648556-92-5MW461.43FormulaC23H22F3N3O4
- CAS number
- 2648556-92-5
- Molecular weight
- 461.43
- Formula
- C23H22F3N3O4
- Solubility
- DMSO: 100 mg/mL (216·72 mM; ultrasonic and warming and heat to 60°C)
- InChIKey
- AETHHGASMIIOSO-UHFFFAOYSA-N
- Catalogue number
- GC75611
- Brand
- GLPBIO
Computed properties PubChem CID 156405796 · XLogP 4.4 · TPSA 85.1 Ų · H-bond donors 1
- XLogP
- 4.4
- TPSA
- 85.1 Ų
- H-bond donors
- 1
- H-bond acceptors
- 8
- Rotatable bonds
- 5
- Heavy atoms
- 33
SMILES CN1C2=CC=CC=C2C(=C(C1=O)C(=O)N)N3CCC(CC3)OC4=CC=C(C=C4)OC(F)(F)F
Computed descriptors from PubChem (CID 156405796), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il